These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19237282)

  • 1. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
    Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists.
    Lim JW; Oh Y; Kim JH; Oak MH; Na Y; Lee JO; Lee SW; Cho H; Park WK; Choi G; Kang J
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2099-102. PubMed ID: 20223662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.
    Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.
    Xia M; Hou C; DeMong DE; Pollack SR; Pan M; Brackley JA; Jain N; Gerchak C; Singer M; Malaviya R; Matheis M; Olini G; Cavender D; Wachter M
    J Med Chem; 2007 Nov; 50(23):5561-3. PubMed ID: 17929797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor.
    Doyon J; Coesemans E; Boeckx S; Buntinx M; Hermans B; Van Wauwe JP; Gilissen RA; De Groot AH; Corens D; Van Lommen G
    ChemMedChem; 2008 Apr; 3(4):660-9. PubMed ID: 18188859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted dipiperidine alcohols as potent CCR2 antagonists.
    Xia M; Hou C; Demong D; Pollack S; Pan M; Brackley J; Singer M; Matheis M; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3562-4. PubMed ID: 18487045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
    Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Arylpyrimidines: novel CRF-1 receptor antagonists.
    Yoon T; De Lombaert S; Brodbeck R; Gulianello M; Krause JE; Hutchison A; Horvath RF; Ge P; Kehne J; Hoffman D; Chandrasekhar J; Doller D; Hodgetts KJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4486-90. PubMed ID: 18672365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
    Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists.
    Sato N; Jitsuoka M; Ishikawa S; Nagai K; Tsuge H; Ando M; Okamoto O; Iwaasa H; Gomori A; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1670-4. PubMed ID: 19233647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.
    Bonjoch J; Diaba F; Pagès L; Pérez D; Soca L; Miralpeix M; Vilella D; Anton P; Puig C
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4299-302. PubMed ID: 19505824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles.
    McAtee JJ; Dodson JW; Dowdell SE; Erhard K; Girard GR; Goodman KB; Hilfiker MA; Jin J; Sehon CA; Sha D; Shi D; Wang F; Wang GZ; Wang N; Wang Y; Viet AQ; Yuan CC; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3716-9. PubMed ID: 18524591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach.
    Ueda S; Kato M; Inuki S; Ohno H; Evans B; Wang ZX; Peiper SC; Izumi K; Kodama E; Matsuoka M; Nagasawa H; Oishi S; Fujii N
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4124-9. PubMed ID: 18539453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.
    Nair PC; Srikanth K; Sobhia ME
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1323-30. PubMed ID: 18258426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
    Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiro-piperidine azetidinones as potent TRPV1 antagonists.
    Xiao D; Palani A; Aslanian R; McKittrick BA; McPhail AT; Correll CC; Phelps PT; Anthes JC; Rindgen D
    Bioorg Med Chem Lett; 2009 Feb; 19(3):783-7. PubMed ID: 19114307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.